Patent · US Expired

Organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1a

US7807148B2 · kind B2 · utility

9Cited by
14References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 19, 2004
Grant dateOct 5, 2010
Priority date
Expiry dateJun 2, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2502/99
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to in vitro cultured skin tissue, and in particular to cultured skin tissue comprising exogenous genes encoding angiogenic growth factors. In some embodiments, the keratinocytes express exogenous angiopoietin-1, HIF-1α, or a member of the VEGF family, preferably VEGF-A. In particularly preferred embodiments, the keratinocytes are incorporated into cultured skin tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.